Immunophenotyping Pattern and Treatment Outcome After Completion of Induction Remission in Children with Acute Lymphoblastic Leukemia

被引:0
|
作者
Karim, M. A. [1 ]
Diba, F. [1 ]
机构
[1] Bangabandhu Sheikh Mujib Med Univ, Pediat Hematol & Oncol, Dhaka, Bangladesh
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-071
引用
收藏
页码:S126 / S126
页数:1
相关论文
共 50 条
  • [21] Hematological parameters and remission induction of childhood acute lymphoblastic leukemia
    Perdani, Roro R. W.
    Sudarmanto, Bambang
    PAEDIATRICA INDONESIANA, 2018, 58 (02) : 71 - 74
  • [22] Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
    Woolfrey, AE
    Anasetti, C
    Storer, B
    Doney, K
    Milner, LA
    Sievers, EL
    Carpenter, P
    Martin, P
    Petersdorf, E
    Appelbaum, FR
    Hansen, JA
    Sanders, JE
    BLOOD, 2002, 99 (06) : 2002 - 2008
  • [23] Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia
    Sandlund, JT
    Harrison, PL
    Rivera, G
    Behm, FG
    Head, D
    Boyett, J
    Rubnitz, JE
    Gajjar, A
    Raimondi, S
    Ribeiro, R
    Hudson, M
    Relling, M
    Evans, W
    Pui, CH
    BLOOD, 2002, 100 (01) : 43 - 47
  • [24] BIOLOGIC FEATURES AND TREATMENT OUTCOME OF ACUTE LYMPHOBLASTIC LEUKEMIA IN LEBANESE CHILDREN
    Muwakkit, Samar
    Al-Aridi, Carol
    Saab, Rays
    Eid, Dalia
    Mahfouz, Rami
    Farra, Chantal
    Samra, Ahmad
    Abboud, Miguel
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 860 - 861
  • [25] Clinical features and treatment outcome of children with acute lymphoblastic leukemia and hyperleukocytosis
    Rodriguez-Aguirre, Manuel, I
    Hernandez-Cuellar, Esperanza
    Espinoza-Roman, Victor H.
    Acevedo-Segura, Virna G.
    Lagos-Cordova, Elda Y.
    Vera-Morales, Carlos D.
    Vazquez-Garcia, Ruben E.
    Palomo-Colli, Miguel A.
    GACETA MEXICANA DE ONCOLOGIA, 2021, 20 : S23 - S27
  • [26] Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia
    Tong, Wing H.
    Mertens, Bart J.
    de Faber, Jan T.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (11)
  • [27] Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens
    Brodtman, DH
    Rosenthal, DW
    Redner, A
    Lanzkowsky, P
    Bonagura, VR
    JOURNAL OF PEDIATRICS, 2005, 146 (05): : 654 - 661
  • [28] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
    Rocha, JCC
    Cheng, C
    Liu, W
    Kishi, S
    Das, S
    Cook, EH
    Sandlund, JT
    Rubnitz, J
    Ribeiro, R
    Campana, D
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2005, 105 (12) : 4752 - 4758
  • [29] Outcome of children cured of acute lymphoblastic leukemia
    Tabone, Marie-Dominique
    Leverger, Guy
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2009, 193 (07): : 1519 - 1528
  • [30] Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
    Eréndira Mejía-Aranguré
    Alfonso Reyes-López
    Luis Enrique Juárez-Villegas
    Yosef Olaf Hernández-Olivares
    Alberto Daniel Saucedo-Campos
    Gabriela Hernández-Pliego
    Silvia Martínez-Valverde
    Leticia A. Barajas-Nava
    Juan Garduño-Espinosa
    BMC Health Services Research, 22